Pharma Care System: A Case Study

Satisfactory Essays

Firstly, our current pharmacare system does not provide access to individuals who need prescription drugs and are unable to afford it (Morgan, Daw and Law 2014). Prescription drugs are inputs into the broader health care system. As such, if prescription drugs are taken on time, this allows the healthcare system to meet patient health needs (Morgan, Daw and Law 2014). Secondly, our current pharmacare system does not ensure that the financial costs associated with necessary medicine are equally distributed (Morgan, Daw and Law 2014). Unequal distribution of the costs of necessary medicine can further drive income inequality (Morgan, Daw and Law 2014). Also, employers are under no obligation to continue providing private insurance for their employees …show more content…

Firstly, all Canadians should have access to medically necessary prescription drugs (Morgan, et al. 2015). Studies show that 1 in 10 Canadians does not take their medicine as prescribed because of costs (Morgan, et al. 2015). In a few cases, Canadians do not purchase prescribed drugs because they lack adequate drug coverage. A national pharmacare plan would allow millions of Canadians access to medically necessary drugs.
Secondly, a national pharmacare program resolves the problems of underuse of needed therapy (Morgan, et al. 2015). The current system separates the management of medicine from the management of health care; consequently, this approach negatively impacts the safe and effective use of medicines (Morgan, et al. 2015). Studies reveal that one in three elderly Canadians receive prescriptions for drugs known to pose health risks for older patients (Morgan, et al. 2015). Canada needs a program to ensure the safe use of …show more content…

2015). Costs such as administrative costs and drug prices are not streamlined to achieve better health outcomes for the amount of money invested in the healthcare system (Morgan, et al. 2015). Administrative costs, including patient enrollment, revenue collection, and claims administration are repetitive; consequently, this approach draws resources away from purchasing a national pharmacare program (Morgan, et al. 2015). In terms of drug prices, Canada is one of the most expensive countries in the world. Generic-drug prices in Canada are nearly double the prices found in other OECD (Organization for Economic Cooperation and Development) countries (Morgan, et al. 2015). Healthcare systems in other developed

Get Access